Satellite Banner
Technology Networks Header
Friday, December 19, 2014
Technology Networks
 
Register | Sign in
Home Page > Latest Webcasts
  Webcasts
Scientific News
53 Approved Drugs that May Block Ebola Infection Identified
Compounds may keep virus from entering cells and could accelerate drug development.
New Research Unlocks a Mystery of Albinism
A team led by Brown University biologists has discovered the way in which a specific genetic mutation appears to lead to the lack of melanin production underlying a form of albinism.
Biomarker Discovery Sheds New Light on Heart Attack Risk of Arthritis Drugs
Drug may be given a new lease of life.
New Way To Turn Genes On
Technique allows rapid, large-scale studies of gene function.
Metal Test Could Help Diagnose Breast Cancer Early
It may be possible to develop a simple blood test that, by detecting changes in the zinc in our bodies, could help to diagnose breast cancer early.
Reducing Chemotherapy Drug’s Cardiac Side Effects
Preventing doxorubicin-induced cardiotoxicity could improve chemotherapy outcomes, reduce heart failure risk.
New Approach Holds Promise for Dengue Fever
An exclusive partnering deal to develop Fenretinide for dengue fever.
Stroke Damage Mechanism Identified
Researchers have discovered a mechanism linked to the brain damage often suffered by stroke victims—and are now searching for drugs to block it.
Two Studies Identify A Detectable, Pre-Cancerous State In The Blood
Findings pave way for new lines of cancer research focused on detection and prevention.
Antibiotic Resistance Threatens Future of Modern Medicine
Overuse and misuse of antibiotics, one of the key contributors to antimicrobial resistance (AMR).
Scroll Up
Scroll Down
Return
Chemical Probe Discovery in the Academic Sector Through the NIH Roadmap Molecular Libraries Program from the Pilot to Production Phase
Thomas Chung, Project Manager, Conrad Prebys Center for Chemical Genomics, Burnham Institute for Medical Research, speaking at Probe Discovery 2009
Date Posted: Sunday, August 15, 2010
Print Page

For access to this article, enter your email address to instantly recieve a Password Reset link.

Please enter your email address below:

Existing users please Sign In here. Don't have an account? Register Here for free access.

Don't have an account? | Register Here



Burnham Announces License Agreement with Johnson & Johnson Pharmaceutical Research & Development
Burnham to provide J&JPRD with access to high-throughput assay screening technologies to investigate certain drug targets for inflammatory diseases.
Wednesday, January 14, 2009
 
Skyscraper Banner
SELECTBIO Market Reports
LabTube - Videos for the Scientific Community
eposters - The Online Journal of Scientific Posters
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn